A Study to Create a Biobank of Fallopian Tube Organoids (Small, Simplified Organs) in Women Undergoing Salpingectomy (Surgical Removal of the Fallopian Tubes)

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Jacksonville, Florida: 18-001967
    • Rochester, Minnesota: 18-001967
    Sponsor Protocol Number: 18-001967

About this study

The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • All women undergoing salpingectomy surgeries are eligible.
  • Age ≥ 18 years must be able to understand and willing to sign an informed consent document.

Exclusion Criteria:

  • Any history of or currently having medical conditions that prohibit the understanding or rendering of informed consent such as dementia, altered mental status, psychiatric conditions.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Nagarajan Kannan, Ph.D., M.S.

Contact us for the latest status

Contact information:

Kimberly McCoy

(904)953-0408

McCoy.Kimberly1@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Nagarajan Kannan, Ph.D., M.S.

Open for enrollment

Contact information:

Kaitlin Schwartz

(507)293-9114

Schwartz.Kaitlin@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20424758

Mayo Clinic Footer